scholarly journals Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Sebastian M. Christ ◽  
Maiwand Ahmadsei ◽  
Annina Seiler ◽  
Eugenia Vlaskou Badra ◽  
Jonas Willmann ◽  
...  

Abstract Introduction and background As cancer is developing into a chronic disease due to longer survival, continuity and coordination of oncological care are becoming more important for patients. As radiation oncology departments are an integral part of cancer care and as repeat irradiation becomes more commonplace, the relevance of continuity and coordination of care in operating procedures is increasing. This study aims to perform a single-institution analysis of cancer patients in which continuity and coordination of care matters most, namely the highly selected group with multiple repeat course radiotherapy throughout their chronic disease. Materials and methods All patients who received at least five courses of radiotherapy at the Department of Radiation Oncology at the University Hospital Zurich from 2011 to 2019 and who were alive at the time of the initiation of this project were included into this study. Patient and treatment characteristics were extracted from the hospital information and treatment planning systems. All patients completed two questionnaires on continuity of care, one of which was designed in-house and one of which was taken from the literature. Results Of the 33 patients identified at baseline, 20 (60.6%) participated in this study. A median of 6 years (range 3–13) elapsed between the first and the last visit at the cancer center. The median number of involved primary oncologists at the radiation oncology department was two (range 1–5). Fifty-seven percent of radiation therapy courses were preceded by a tumor board discussion. Both questionnaires showed high levels of experienced continuity of care. No statistically significant differences in experienced continuity of care between groups with more or less than two primary oncologists was found. Discussion and conclusion Patients treated with multiple repeat radiation therapy at our department over the past decade experienced high levels of continuity of care, yet further efforts should be undertaken to coordinate care among oncological disciplines in large cancer centers through better and increased use of interdisciplinary tumor boards.

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e17501-e17501
Author(s):  
K. Scher ◽  
D. M. Tisnado ◽  
D. Rose-Ash ◽  
A. Rastegar ◽  
J. Adams ◽  
...  

e17501 Background: Coordination of care has grown in importance with the advent of new modalities of treatment requiring specialized expertise. In cancer care, multidisciplinary approaches have shown improvements in quality of care and patient satisfaction. Tumor boards provide a mechanism for improving coordination of care. We evaluated physician and practice characteristics that predict frequency of tumor board attendance. Methods: This cross-sectional study utilizes data obtained by surveying physicians of a population-based sample of women with incident breast cancer. Physicians were queried regarding tumor board attendance, specialty (medical oncologist [MO], radiation oncologist [RO], surgeon indicating that the hospital at which most breast cancer surgeries are performed has an American College of Surgeons accredited program [ACOSSg] and surgeon without such affiliation [non-ACOSSg]), physician characteristics (gender, race, teaching involvement, patient volume, number of offices, ownership interest), and practice setting (practice type, size, reimbursement). Univariate, bivariate, and multivariate analyses were performed for the dependent variable characterizing provider report of frequency of tumor board meeting attendance. Results: Most surveyed physicians (83%) report attending tumor board weekly (58%) or monthly (25%). Weekly participation was reported by 63%, 92%, 47%, and 32% of MOs, ROs, ACOSSgs, and non-ACOSSgs (p < 0.01). Specialty and higher patient volumes are significant predictors of more frequent attendance, after adjustment for practice size and type. In comparison to the most prevalent specialty category (low volume ACOSSgs), high volume MOs attend more (p = 0.01), and low volume non-ACOSSgs attend less frequently (p = 0.00). Conclusions: Tumor board attendance implies increased participation in multidisciplinary care, but specific subsets of providers are less frequent users. This not only has implications for choosing providers, but also for efforts to increase attendance. Tumor board agendas and formalized institution wide policies could be designed to further engage low frequency attendees as a means to promote multidisciplinary care and improve health outcomes. [Table: see text]


2011 ◽  
Vol 11 (2) ◽  
pp. 74-82 ◽  
Author(s):  
S. Oultram ◽  
N. Findlay ◽  
K. Clover ◽  
L. Cross ◽  
L. Ponman ◽  
...  

AbstractPurpose: The purpose of this study is to identify the incidence of anxiety and distress among patients requiring immobilization during radiation therapy to the head and neck region; then to compare this with radiation therapists’ ability to identify anxiety in the same group of patients.Materials and methods: Data from a sample of 70 patients requiring an immobilization mask participated in this study. Patient self-report assessments and radiation therapists’ ratings were recorded at two time points, CT-Simulation and fraction 1 of treatment. Self-reported patient anxiety was assessed with the Brief Symptom Inventory-18. To determine radiation therapists’ ratings of patient anxiety, two rating scales were developed.Results: Patient self-report identified anxiety in 16% and 14% of patients at CT Simulation and fraction 1 of treatment, respectively. Radiation therapists identified anxiety in 24% patients at time point one and in 44% of patients at time point two.Conclusion: There was slight agreement between patient self-reported levels of anxiety and radiation therapists’ ratings of patient anxiety. This study suggests that there is scope for further investigation into the identification and management of anxiety and distress in head and neck cancer patients requiring immobilization.


2021 ◽  
Author(s):  
Niklas Reimer ◽  
Philipp Unberath ◽  
Hauke Busch ◽  
Melanie Börries ◽  
Patrick Metzger ◽  
...  

In Molecular Tumor Boards (MTBs), therapy recommendations for cancer patients are discussed. To aid decision-making based on the patient’s molecular profile, the research platform cBioPortal was extended based on users’ requirements. Additionally, a comprehensive dockerized workflow was developed to support the deployment of cBioPortal and connected services. In this work, we present the challenges and experiences of nearly two years of implementing and deploying an MTB platform based on cBioPortal and compare those to findings of a previous study.


2018 ◽  
Vol 09 (02) ◽  
pp. 377-390 ◽  
Author(s):  
Eric Zapletal ◽  
Jean-Emmanuel Bibault ◽  
Philippe Giraud ◽  
Anita Burgun

Background Clinical data warehouses are now widely used to foster clinical and translational research and the Informatics for Integrating Biology and the Bedside (i2b2) platform has become a de facto standard for storing clinical data in many projects. However, to design predictive models and assist in personalized treatment planning in cancer or radiation oncology, all available patient data need to be integrated into i2b2, including radiation therapy data that are currently not addressed in many existing i2b2 sites. Objective To use radiation therapy data in projects related to rectal cancer patients, we assessed the feasibility of integrating radiation oncology data into the i2b2 platform. Methods The Georges Pompidou European Hospital, a hospital from the Assistance Publique – Hôpitaux de Paris group, has developed an i2b2-based clinical data warehouse of various structured and unstructured clinical data for research since 2008. To store and reuse various radiation therapy data—dose details, activities scheduling, and dose-volume histogram (DVH) curves—in this repository, we first extracted raw data by using some reverse engineering techniques and a vendor's application programming interface. Then, we implemented a hybrid storage approach by combining the standard i2b2 “Entity-Attribute-Value” storage mechanism with a “JavaScript Object Notation (JSON) document-based” storage mechanism without modifying the i2b2 core tables. Validation was performed using (1) the Business Objects framework for replicating vendor's application screens showing dose details and activities scheduling data and (2) the R software for displaying the DVH curves. Results We developed a pipeline to integrate the radiation therapy data into the Georges Pompidou European Hospital i2b2 instance and evaluated it on a cohort of 262 patients. We were able to use the radiation therapy data on a preliminary use case by fetching the DVH curve data from the clinical data warehouse and displaying them in a R chart. Conclusion By adding radiation therapy data into the clinical data warehouse, we were able to analyze radiation therapy response in cancer patients and we have leveraged the i2b2 platform to store radiation therapy data, including detailed information such as the DVH to create new ontology-based modules that provides research investigators with a wider spectrum of clinical data.


2013 ◽  
Vol 31 (31_suppl) ◽  
pp. 241-241 ◽  
Author(s):  
Patricia H. Hardenbergh ◽  
Brigitta Gehl ◽  
Kimberly Anne Lyons-Mitchell

241 Background: The purpose of this project is to improve the quality of cancer care by connecting disease site-specific experts with community oncologists through web-based technology. Methods: Chartrounds.com is a conferencing web-site developed to allow community oncologists to present real cases to disease site specialists in oncology on a scheduled basis. Chartrounds was developed initially for radiation oncologists and subsequently has expanded to include multidisciplinary tumor boards and medical oncology specific sessions. Presently 43 disease site expert oncologists including surgeons, medical oncologists and radiation oncologists from 38 academic institutions in the US host sessions. Feedback reports following the completion of each session were designed to assess the impact of the project. Results: Since its inception in December 2010, 43 disease site-specialists have lead 366 sessions, connecting 3,793 participating oncologists from all 50 US states and 24 countries.Broken down by specialty, 348 radiation oncology sessions have linked 3,632 participants, 14 medical oncology specific and multidisciplinary tumor board sessions have included 161 participants. On a 5 point Likert scale with 5 representing the greatest possible impact, the mean response to feedback questions is as follows: session quality: 4.7 for radiation oncology, 4.6 for multidisciplinary; time used effectively: 4.6 for radiation oncology, 4.5 for multidisciplinary; discussions relevant to daily practice: 4.6 for radiation oncology, 4.6 for multidisciplinary; session is likely to result in a change of practice: 4.0 for radiation oncology, 4.0 for multidisciplinary. Chartrounds sessions qualify for 1 CME credit and is approved for a practice quality improvement project by the American Board of Radiology. Conclusions: Chartrounds.com is impacting oncology practices which results in changes in community practice. Future directions of this project include providing chartrounds sessions for oncology nurses and providing a library of video recorded archived sessions. This work has been funded by the Improving Cancer Care Grant of the ASCO Conquer Cancer Foundation.


2014 ◽  
Vol 32 (4_suppl) ◽  
pp. 151-151
Author(s):  
Ketan K. Badani ◽  
Darby J. S. Thompson ◽  
Christine Buerki ◽  
Amar Singh

151 Background: Clinical guidelines recommend adjuvant radiation therapy (ART) after radical prostatectomy in men with adverse pathological features. Practice patterns vary on use of ART. This prospective, multi-center study examines the effect of a genomic classifier (GC) on ART recommendations post-prostatectomy. Methods: A prospective, pre-post tumor-board–like survey was conducted to assess urologists’ treatment recommendations for ART as part of a clinical utility study; results are from a pre-specified interim analysis of 11 unique de-identified cases with adverse pathology. All case histories were based on patients treated by at least one of the urologists participating in the study. Patient age, pathological features, and preoperative prostate-specific antigen were presented to the respondents. Presentation of cases was randomized to minimize recall bias. For each case history, physician respondents first were asked to render an ART recommendation without knowledge of the GC findings (pre-GC); they were then asked to render an ART recommendation after GC findings were provided for the same cases (post-GC). Recommendations were made without knowledge of others’ responses. Results: Twelve urologists at 11 US institutions provided 132 adjuvant therapy recommendations. Pre-GC, ART was recommended in 56 (42%) cases. Thirty three percent (95% CI: 25-41%) of recommendations changed following review of GC results. Among pre-GC recommendations for ART, 39% (95% CI: 27-53%; n=22) changed to observation and among pre-GC recommendations for observation, 8% (95% CI: 3%-17%; n=5) changed to ART. Compared to observation, ART was 11.8 times (odds ratio 95% CI: 2.9 - 46.3) more likely to be recommended for cases with high risk GC scores. Adjuvant therapy recommendations were more strongly influenced by GC score (p=0.0006) than any clinical variable (all p>0.33) when both informed recommendations. Conclusions: Additional knowledge of the tumor’s genomic characteristics, as assessed by GC, results in a statistically significant and clinically meaningful change in treatment recommendations in patients indicated for adjuvant radiation therapy by current clinical guidelines.


Sign in / Sign up

Export Citation Format

Share Document